Исследование показало, что лечение аденомы простаты с iTind действует более четырех лет USA – Pусский USA – English USA – Deutsch

ГАМБУРГ, Германия, 13 июля 2023 г /PRNewswire/ — Olympus Corporation, международная компания в области медицинских технологий, объявила о публикации данных исследования, свидетельствующих о том, что минимально инвазивная терапия iTind™ позволяет надолго, более чем на четыре года, облегчить состояние людей, страдающих от симптомов увеличенной простаты, известной также как ДГПЖ. The iTind™ procedure involves the placement of … Read more

Immunovia to Significantly Restructure to Focus Resources on its Next-Generation Blood Test for Pancreatic Cancer Detection

LUND, Sweden, July 12, 2023 /PRNewswire/ — Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company focused on early detection of pancreatic cancer, today announced plans to restructure its operations. The company will cease commercialization of its IMMray PanCan-d test in the United States to focus its resources on the further development and clinical testing of the … Read more

CVS Health announces quarterly dividend

WOONSOCKET, R.I., July 7, 2023 /PRNewswire/ — CVS Health (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty and a half cents ($0.605 cents) per share on the Common Stock of the Corporation. The dividend is payable on August 1, 2023, to holders of record on July 21, … Read more

Rise in Awareness Regarding CAR T-Cell Therapy Drives Growth

DUBLIN, July 6, 2023 /PRNewswire/ — The “CAR-T Cell Therapy Market Share, Size, Trends, Industry Analysis Report, By Target Antigen, By Indication, By Region, Segment Forecast, 2023-2032” report has been added to  ResearchAndMarkets.com’s offering. The global CAR-T cell therapy market size is expected to reach USD 118,680.68 million by 2032, according to a new study. This … Read more

CAR T-Cell Study Enabled by 10x Genomics Single Cell Technology Published in Nature Medicine

Data Uncovers New Gene Signature to Help Understand Persistence in CAR T-cells PLEASANTON, Calif., July 5, 2023 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that its single-cell genomic technologies were used in a study published in the journal Nature Medicine about new gene signatures that explain why some … Read more

High Prevalence of Respiratory Diseases to Drive Growth of Oxygen Equipment and Nebulizers

DUBLIN, June 16, 2023 /PRNewswire/ — The “Durable Medical Equipment: Global Strategic Business Report” report has been added to  ResearchAndMarkets.com’s offering. The global market for Durable Medical Equipment estimated at US$207.1 Billion in the year 2022, is projected to reach a revised size of US$363 Billion by 2030, growing at a CAGR of 7.3% over the analysis … Read more

Wider Search Needed to Better Treat Eosinophilic Food Allergy

Eliminating eosinophils not enough to improve outcomes for eosinophilic gastritis. Tweet this These paradigm-shifting Phase 2 clinical trial results were published online June 16, 2023, in The Lancet Gastroenterology & Hepatology. “Our findings suggest that the mechanisms driving this disease are in large part independent of excessive eosinophil production. That means our attention should turn … Read more

Demand for Natural Vitamin E is Projected to Reach About 20K Metric Tons by 2028

DUBLIN, June 16, 2023 /PRNewswire/ — The “Natural Source Vitamin E (Tocopherols and Tocotrienols) – A Global Market Overview” report has been added to ResearchAndMarkets.com’s offering. Global demand for Natural Source Vitamin E reached US$1.1 billion in 2022, registering a YOY growth of 17% attributed to huge price increase in Tocopherols.  Dietary Supplements sector is the … Read more

DMS HEALTH TECHNOLOGIES PROVIDES NOTICE OF DATA EVENT

WEST FARGO, N.D., June 16, 2023 /PRNewswire/ — DMS Health Technologies (“DMS”) recently discovered an incident that may have impacted the privacy of information related to certain individuals. While DMS is unaware of any actual or attempted misuse of information in relation to the incident, it is providing potentially affected individuals with information about the … Read more

FDA Roundup: June 16, 2023

SILVER SPRING, Md., June 16, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA posted information on its website regarding the formula for COVID-19 vaccines for the 2023-2024 fall and winter seasons. The FDA has advised manufacturers seeking to update … Read more